"Care decisions are best made between physicians and their patients and families." Corewell Health has decided to reverse ...
Corewell Health says it will resume allowing minors who are seeking gender-affirming care to start new hormone therapy ...
Using hormone replacement therapy (HRT) to reduce cardiovascular risk during menopause remains a topic of debate. The ...
Republicans currently have enough votes to override Gov. Laura Kelly's veto and ban gender-affirming health care for minors.
Dr. Debu Tripathy discusses the FDA approval of Enhertu in unresectable or metastatic hormone receptor HR+, HER2-low or -ultralow breast cancer.
Corewell Health reversed the decision Wednesday, saying "decisions are best made between physicians and their patients and ...
When prostate cancer patients need therapy to reduce male hormone levels, delivering some of the treatment via a patch on the skin may be just as effective as traditional means of administration with ...
Stroke experts from UCSF Health presented new research and clinical findings at the annual the American Stroke Association’s International Stroke Conference (ISC25), the world’s premier meeting ...
State employees who use the state-sponsored health plan may soon be blocked from receiving gender-affirming care like hormone ...
The Trump administration withdraws from the gender-affirming care dispute at the Supreme Court, shifting their stance from opposing to supporting Tennessee's ban on such care for minors.
"Since something was happening to harm our community we had to take action," Julia Music, Ferndale Pride's exeutive director said.
Breast cancers at all stages are defined by the structure of their genomes, researchers find. Targeting these processes early is likely to offer unexpected therapeutic avenues.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results